<?xml version="1.0" encoding="UTF-8"?>
<ref id="B151-pharmaceuticals-12-00157">
 <label>151.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sperandio</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Barat</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Cabrita</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Gargaun</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Berezovski</surname>
    <given-names>M.V.</given-names>
   </name>
   <name>
    <surname>Tremblay</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>de Belle</surname>
    <given-names>I.</given-names>
   </name>
  </person-group>
  <article-title>TOE1 is an inhibitor of HIV-1 replication with cell-penetrating capability</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2015</year>
  <volume>112</volume>
  <fpage>E3392</fpage>
  <lpage>E3401</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.1500857112</pub-id>
  <pub-id pub-id-type="pmid">26056259</pub-id>
 </element-citation>
</ref>
